+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Vaccine Contract Manufacturing Market Size, Share & Trends Analysis Report by Vaccine Type (Attenuated, Inactivated), Workflow (Downstream, Upstream), Application (Human, Veterinary), Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 133 Pages
  • March 2024
  • Region: Global
  • Grand View Research
  • ID: 5950086
Description Jump to:
The global vaccine contract manufacturing market size is expected to reach USD 3.60 billion by 2030 and it is projected to grow at a CAGR of 7.8% from 2024 to 2030. The market is anticipated to witness the significant CAGR over the forecast period, thanks to rising demand for vaccine development from the private sector as well as governments in industrialized and developing countries.

Vaccine contract services offer cost-saving benefits to their clients. They also help save time in the operations and management of a production and research facility. These advantages associated with Contract Manufacturing Organizations (CMOs) are expected to benefit emerging players, start-ups, and small players who lack adequate facilities and resources required for vaccine development.

Vaccination coverage is increasing across the globe. According to data published by the Pan American Health Organization, in 2022, the regional coverage of DPT3 was 85%. 13 countries and territories attained a DPT3-containing vaccine coverage of 95%, while 14 others reported 80% coverage across all municipalities. In addition, 21 countries reported an improvement in their DPT3 coverage from 2021 to 2022.Moreover, according to WHO, the percentage of children receiving the initial dose of the measles vaccine rose from 81% in 2021 to 83% in 2022; however, this remains below the 2019 level of 86%. On a global scale, the coverage for the first dose of HPV in girls increased from 16% in 2021 to 21% in 2022.

Furthermore, key companies in the market are undertaking various strategic initiatives to expand their market presence and product reach. For instance, in June 2023, Lonza and Vertex Pharmaceuticals, Inc. announced a strategic partnership to scale up manufacturing and support commercial production of Vertex's T1D cell therapy portfolio. They planned to further co-invest to build a dedicated facility in Portsmouth, New Hampshire (U.S.). Moreover, in January 2023, Catalent, Inc. signed a development and license agreement with Ethicann Pharmaceuticals Inc. to develop Ethicann's clinical drug pipeline using Catalent's Zydis Orally Disintegrating Tablet (ODT) technology. This was aimed to ensure improved patient acceptance and convenience.

Vaccine Contract Manufacturing Market Report Highlights

  • Contract services for the development of attenuated vaccines accounted for the major share in the market based on vaccine type. This can be attributed to the fact that these vaccines offer immunity for a lifetime with only one or two doses
  • DNA vaccines form the fastest-growing segment by type, with several kinds already being tested on humans
  • Based on workflow, downstream processing dominated the market mainly due to the necessity of mature and reliable biotechnology tools for product recovery. Various research initiatives in the space are also contributing to advancing downstream workflows
  • Based on application, contract services for the development of human-use vaccines held the largest share owing to their high adoption to develop vaccines against influenza and other illnesses
  • North America dominated the overall market with revenue share of over 33.58% in 2023. This can be attributed to the presence of a substantial number of vaccine contract manufacturers in the U.S. Presence of an effective regulatory framework for biologics, including vaccines

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal database
1.5. Details of Primary Research
1.5.1. Data For Primary Interviews In North America
1.5.2. Data For Primary Interviews In Europe
1.5.3. Data For Primary Interviews In Asia Pacific
1.5.4. Data For Primary Interviews In Latin America
1.5.5. Data for Primary Interviews In MEA
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis (Model 1)
1.7.1.1. Approach 1: Commodity Flow Approach
1.7.2. Volume price analysis (Model 2)
1.7.2.1. Approach 2: Volume Price Analysis
1.8. Research Scope and Assumptions
1.8.1. List of Secondary Sources
1.8.2. List of Primary Sources
1.8.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Vaccine Contract Manufacturing Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Capacity Expansion By Contract Manufacturers For Vaccine Manufacturing
3.2.1.2. Global Increase in Vaccination Coverage
3.2.1.3. Vaccination Innovation and Robust Vaccine Pipeline
3.2.1.4. Cost and Time-Saving Benefits Offered By Contract Services
3.2.2. Market Restraint Analysis
3.2.2.1. Limited Outsourcing By Well-Established Vaccine Manufacturers
3.3. Vaccine Contract Manufacturing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining Power of The Suppliers
3.3.1.2. Bargaining Power of The Buyers
3.3.1.3. Threats of Substitution
3.3.1.4. Threats From New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological Landscape
Chapter 4. Vaccine Contract Manufacturing Market: Vaccine Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Vaccine Contract Manufacturing Market: Type Movement Analysis
4.3. Global Vaccine Contract Manufacturing Market Size & Trend Analysis, By Type, 2018 to 2030 (USD Million)
4.4. Attenuated Vaccine
4.4.1. Attenuated Vaccine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Inactivated Vaccine
4.5.1. Inactivated Vaccine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Subunit Vaccines
4.6.1. Subunit Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Toxoid Vaccines
4.7.1. Toxoid Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. DNA Vaccines
4.8.1. DNA Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Vaccine Contract Manufacturing Market: Workflow Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Vaccine Contract Manufacturing Market: Workflow Movement Analysis
5.3. Global Vaccine Contract Manufacturing Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
5.4. Downstream
5.4.1. Downstream Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.2. Fill & Finish Operations
5.4.2.1. Fill & Finish Operations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.3. Analytical & QC Studies
5.4.3.1. Analytical & QC Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.4. Packaging
5.4.4.1. Packaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Upstream
5.5.1. Upstream Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.2. Mammalian Expression Systems
5.5.2.1. Mammalian Expression Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.3. Bacterial Expression Systems
5.5.3.1. Bacterial Expression Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.4. Yeast Expression Systems
5.5.4.1. Yeast Expression Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.5. Baculovirus/Insect Expression Systems
5.5.5.1. Baculovirus/Insect Expression Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.6. Others
5.5.7. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Vaccine Contract Manufacturing Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Vaccine Contract Manufacturing Market: Application Movement Analysis, USD Million, 2022 & 2030
6.3. Global Vaccine Contract Manufacturing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
6.4. Human Use
6.4.1. Human Use Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Veterinary
6.5.1. Veterinary Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Vaccine Contract Manufacturing Market: Regional Estimates & Trend Analysis, by Services, by Area, by Demographic
7.1. Vaccine Contract Manufacturing Market: Regional Movement Analysis, 2022 & 2030
7.2. North America
7.2.1. North America Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Competitive Scenario
7.2.2.3. Prevalence Insights
7.2.2.4. Regulatory Framework
7.2.2.5. Reimbursement Structure
7.2.2.6. U.S. Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Competitive Scenario
7.2.3.3. Prevalence Insights
7.2.3.4. Regulatory Framework
7.2.3.5. Reimbursement Structure
7.2.3.6. Canada Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Prevalence Insights
7.3.2.4. Regulatory Framework
7.3.2.5. Reimbursement Structure
7.3.2.6. UK Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Prevalence Insights
7.3.3.4. Regulatory Framework
7.3.3.5. Reimbursement Structure
7.3.3.6. Germany Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Prevalence Insights
7.3.4.4. Regulatory Framework
7.3.4.5. Reimbursement Structure
7.3.4.6. France Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Scenario
7.3.5.3. Prevalence Insights
7.3.5.4. Regulatory Framework
7.3.5.5. Reimbursement Structure
7.3.5.6. Italy Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Scenario
7.3.6.3. Prevalence Insights
7.3.6.4. Regulatory Framework
7.3.6.5. Reimbursement Structure
7.3.6.6. Spain Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Scenario
7.3.7.3. Prevalence Insights
7.3.7.4. Regulatory Framework
7.3.7.5. Reimbursement Structure
7.3.7.6. Denmark Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Scenario
7.3.8.3. Prevalence Insights
7.3.8.4. Regulatory Framework
7.3.8.5. Reimbursement Structure
7.3.8.6. Sweden Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Scenario
7.3.9.3. Prevalence Insights
7.3.9.4. Regulatory Framework
7.3.9.5. Reimbursement Structure
7.3.9.6. Norway Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Prevalence Insights
7.4.2.4. Regulatory Framework
7.4.2.5. Reimbursement Structure
7.4.2.6. Japan Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Prevalence Insights
7.4.3.4. Regulatory Framework
7.4.3.5. Reimbursement Structure
7.4.3.6. China Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Prevalence Insights
7.4.4.4. Regulatory Framework
7.4.4.5. Reimbursement Structure
7.4.4.6. India Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. Australia
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Prevalence Insights
7.4.5.4. Regulatory Framework
7.4.5.5. Reimbursement Structure
7.4.5.6. Australia Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. Thailand
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Prevalence Insights
7.4.6.4. Regulatory Framework
7.4.6.5. Reimbursement Structure
7.4.6.6. Thailand Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.7. South Korea
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Prevalence Insights
7.4.7.4. Regulatory Framework
7.4.7.5. Reimbursement Structure
7.4.7.6. South Korea Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Prevalence Insights
7.5.2.4. Regulatory Framework
7.5.2.5. Reimbursement Structure
7.5.2.6. Brazil Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Prevalence Insights
7.5.3.4. Regulatory Framework
7.5.3.5. Reimbursement Structure
7.5.3.6. Mexico Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Prevalence Insights
7.5.4.4. Regulatory Framework
7.5.4.5. Reimbursement Structure
7.5.4.6. Argentina Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East & Africa
7.6.1. Middle East & Africa Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Prevalence Insights
7.6.2.4. Regulatory Framework
7.6.2.5. Reimbursement Structure
7.6.2.6. South Africa Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Prevalence Insights
7.6.3.4. Regulatory Framework
7.6.3.5. Reimbursement Structure
7.6.3.6. Saudi Arabia Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Prevalence Insights
7.6.4.4. Regulatory Framework
7.6.4.5. Reimbursement Structure
7.6.4.6. UAE Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Prevalence Insights
7.6.5.4. Regulatory Framework
7.6.5.5. Reimbursement Structure
7.6.5.6. Kuwait Vaccine Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Company Market Share Analysis, 2023
8.3. Strategy Mapping
8.4. Company Profiles/Listing
8.4.1. Lonza
8.4.1.1. Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. FUJIFILM Diosynth Biotechnologies
8.4.2.1. Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Ajinomoto Co., Inc.
8.4.3.1. Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Merck KGaA
8.4.4.1. Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. IDT Biologika GmbH
8.4.5.1. Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Curia Global, Inc.
8.4.6.1. Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. ICON plc.
8.4.7.1. Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Cytovance Biologics (Hepalink)
8.4.8.1. Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Syngene International Limited
8.4.9.1. Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Catalent, Inc
8.4.10.1. Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 4. Global vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 5. Global vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 6. Global vaccine contract manufacturing market, by region, 2018 - 2030 (USD Million)
Table 7. North America vaccine contract manufacturing market, by country, 2018 - 2030 (USD Million)
Table 8. North America vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 9. North America vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 10. North America vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 11. U.S. vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 12. U.S. vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 13. U.S. vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 14. Canada vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 15. Canada vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 16. Canada vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 17. Europe vaccine contract manufacturing market, by country, 2018 - 2030 (USD Million)
Table 18. Europe vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 19. Europe vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 20. Europe vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 21. Germany vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 22. Germany vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 23. Germany vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 24. UK vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 25. UK vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 26. UK vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 27. France vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 28. France vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 29. France vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 30. Italy vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 31. Italy vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 32. Italy vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 33. Spain vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 34. Spain vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 35. Spain vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 36. Denmark vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 37. Denmark vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 38. Denmark vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 39. Sweden vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 40. Sweden vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 41. Sweden vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 42. Norway vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 43. Norway vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 44. Norway vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 45. Asia Pacific vaccine contract manufacturing market, by country, 2018 - 2030 (USD Million)
Table 46. Asia Pacific vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 47. Asia Pacific vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 48. Asia Pacific vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 49. China vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 50. China vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 51. China vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 52. Japan vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 53. Japan vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 54. Japan vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 55. India vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 56. India vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 57. India vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 58. South Korea vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 59. South Korea vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 60. South Korea vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 61. Australia vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 62. Australia vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 63. Australia vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 64. Thailandvaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 65. Thailandvaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 66. Thailandvaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 67. Latin America vaccine contract manufacturing market, by country, 2018 - 2030 (USD Million)
Table 68. Latin America vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 69. Latin America vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 70. Latin America vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 71. Brazil vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 72. Brazil vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 73. Brazil vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 74. Mexico vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 75. Mexico vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 76. Mexico vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 77. Argentina vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 78. Argentina vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 79. Argentina vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 80. Middle East & Africa vaccine contract manufacturing market, by country, 2018 - 2030 (USD Million)
Table 81. Middle East & Africa vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 82. Middle East & Africa vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 83. Middle East & Africa vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 84. South Africa vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 85. South Africa vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 86. South Africa vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 87. Saudi Arabia vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 88. Saudi Arabia vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 89. Saudi Arabia vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 90. UAE vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 91. UAE vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 92. UAE vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
Table 93. Kuwait vaccine contract manufacturing market, by type, 2018 - 2030 (USD Million)
Table 94. Kuwait vaccine contract manufacturing market, by workflow, 2018 - 2030 (USD Million)
Table 95. Kuwait vaccine contract manufacturing market, by application, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Vaccine Contract Manufacturing Market, Market Segmentation
Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 10 Penetration & Growth Prospect Mapping
Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 12 Porter’s Five Forces Analysis
Fig. 13 Market Penetration Vs Growth Prospect Mapping, 2021
Fig. 14 Regional Marketplace: Key Takeaways
Fig. 15 Global Vaccine Contract Manufacturing Market, for Attenuated Vaccine, 2018 - 2030 (USD Million)
Fig. 16 Global Vaccine Contract Manufacturing Market, for Inactivated Vaccine, 2018 - 2030 (USD Million)
Fig. 17 Global Vaccine Contract Manufacturing Market, for Subunit vaccines, 2018 - 2030 (USD Million)
Fig. 18 Global Vaccine Contract Manufacturing Market, for Toxoid Vaccines, 2018 - 2030 (USD Million)
Fig. 19 Global Vaccine Contract Manufacturing Market, for DNA Vaccines, 2018 - 2030 (USD Million)
Fig. 20 Global Vaccine Contract Manufacturing Market, for Downstream, 2018 - 2030 (USD Million)
Fig. 21 Global Vaccine Contract Manufacturing Market, for Fill & Finish Operations, 2018 - 2030 (USD Million)
Fig. 22 Global Vaccine Contract Manufacturing Market, for Analytical & QC studies, 2018 - 2030 (USD Million)
Fig. 23 Global Vaccine Contract Manufacturing Market, for Packaging, 2018 - 2030 (USD Million)
Fig. 24 Global Vaccine Contract Manufacturing Market, for Upstream, 2018 - 2030 (USD Million)
Fig. 25 Global Vaccine Contract Manufacturing Market, for Mammalian Expression Systems, 2018 - 2030 (USD Million)
Fig. 26 Global Vaccine Contract Manufacturing Market, for Bacterial Expression Systems, 2018 - 2030 (USD Million)
Fig. 27 Global Vaccine Contract Manufacturing Market, for Yeast Expression Systems, 2018 - 2030 (USD Million)
Fig. 28 Global Vaccine Contract Manufacturing Market, for Baculovirus/Insect Expression Systems, 2018 - 2030 (USD Million)
Fig. 29 Global Vaccine Contract Manufacturing Market, for Others, 2018 - 2030 (USD Million)
Fig. 30 Global Vaccine Contract Manufacturing Market, for Human Use, 2018 - 2030 (USD Million)
Fig. 31 Global Vaccine Contract Manufacturing Market, for Veterinary, 2018 - 2030 (USD Million)
Fig. 32 Regional Outlook, 2021 & 2030
Fig. 33 North America Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 34 U.S. Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 35 Canada Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 36 Europe Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 37 Germany Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 38 UK Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 39 France Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 40 Italy Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 41 Spain Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 42 Denmark Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 43 Sweden Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 44 Norway Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 45 Asia Pacific Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 46 Japan Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 47 China Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 48 India Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 49 Australia Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 50 South Korea Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 51 Thailand Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 52 Latin America Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 53 Brazil Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 54 Mexico Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 55 Argentina Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 56 Middle East and Africa Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 57 South Africa Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 58 Saudi Arabia Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 59 UAE Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)
Fig. 60 Kuwait Vaccine Contract Manufacturing Market, 2018 - 2030 (USD Million)

Companies Mentioned

  • Lonza
  • FUJIFILM Diosynth Biotechnologies
  • Ajinomoto Co., Inc.
  • Merck KGaA
  • IDT Biologika GmbH
  • Curia Global, Inc.
  • ICON plc.
  • Cytovance Biologics (Hepalink)
  • Syngene International Limited
  • Catalent, Inc

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages133
PublishedMarch 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 2.14 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.6 Billion
Compound Annual Growth Rate7.8%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Vaccine Contract Manufacturing Market by Type, Function, Application - Global Forecast 2025-2030 - Product Image

Vaccine Contract Manufacturing Market by Type, Function, Application - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Vaccine Contract Manufacturing Market: Industry Trends and Global Forecasts to 2035: Type of Expression System Used (Mammalian, Microbial and Others), Company Size and Geographical Region - Product Image

Vaccine Contract Manufacturing Market: Industry Trends and Global Forecasts to 2035: Type of Expression System Used (Mammalian, Microbial and Others), Company Size and Geographical Region

  • Report
  • 381 Pages
  • Global
From
Vaccine Contract Manufacturing Market Report by Vaccine Type, Workflow, Application, and Region 2024-2032 - Product Image

Vaccine Contract Manufacturing Market Report by Vaccine Type, Workflow, Application, and Region 2024-2032

  • Report
  • 149 Pages
  • Global
From
Vaccine Contract Manufacturing - Global Strategic Business Report - Product Image

Vaccine Contract Manufacturing - Global Strategic Business Report

  • Report
  • 274 Pages
  • Global
From
Vaccine Contract Manufacturing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029 - Product Image

Vaccine Contract Manufacturing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

  • Report
  • 187 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.